Similar articles for PMID: 15488951

Year	Number of Results
1984	1
1986	1
1989	1
1991	1
1992	1
1993	2
1994	6
1995	3
1996	2
1998	1
2000	1
2001	2
2002	1
2003	1
2004	9
2005	17
2006	10
2007	3
2008	5
2009	6
2010	3
2011	2
2012	1
2014	2
2017	1
2018	1
2020	5
2021	7
2022	1
2024	0

1

Molecular characterization of a panel of murine monoclonal antibodies specific for the SARS-coronavirus.

Gubbins MJ, Plummer FA, Yuan XY, Johnstone D, Drebot M, Andonova M, Andonov A, Berry JD. Gubbins MJ, et al. Mol Immunol. 2005 Jan;42(1):125-36. doi: 10.1016/j.molimm.2004.06.032. Mol Immunol. 2005. PMID: 15488951 Free PMC article.

2

Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants.

ter Meulen J, van den Brink EN, Poon LL, Marissen WE, Leung CS, Cox F, Cheung CY, Bakker AQ, Bogaards JA, van Deventer E, Preiser W, Doerr HW, Chow VT, de Kruif J, Peiris JS, Goudsmit J. ter Meulen J, et al. PLoS Med. 2006 Jul;3(7):e237. doi: 10.1371/journal.pmed.0030237. PLoS Med. 2006. PMID: 16796401 Free PMC article.

3

Generation and characterization of human monoclonal neutralizing antibodies with distinct binding and sequence features against SARS coronavirus using XenoMouse.

Coughlin M, Lou G, Martinez O, Masterman SK, Olsen OA, Moksa AA, Farzan M, Babcook JS, Prabhakar BS. Coughlin M, et al. Virology. 2007 Apr 25;361(1):93-102. doi: 10.1016/j.virol.2006.09.029. Epub 2006 Dec 11. Virology. 2007. PMID: 17161858 Free PMC article.

4

Molecular and biological characterization of human monoclonal antibodies binding to the spike and nucleocapsid proteins of severe acute respiratory syndrome coronavirus.

van den Brink EN, Ter Meulen J, Cox F, Jongeneelen MA, Thijsse A, Throsby M, Marissen WE, Rood PM, Bakker AB, Gelderblom HR, Martina BE, Osterhaus AD, Preiser W, Doerr HW, de Kruif J, Goudsmit J. van den Brink EN, et al. J Virol. 2005 Feb;79(3):1635-44. doi: 10.1128/JVI.79.3.1635-1644.2005. J Virol. 2005. PMID: 15650189 Free PMC article.

5

Epitope mapping and biological function analysis of antibodies produced by immunization of mice with an inactivated Chinese isolate of severe acute respiratory syndrome-associated coronavirus (SARS-CoV).

Chou TH, Wang S, Sakhatskyy PV, Mboudjeka I, Lawrence JM, Huang S, Coley S, Yang B, Li J, Zhu Q, Lu S. Chou TH, et al. Virology. 2005 Mar 30;334(1):134-43. doi: 10.1016/j.virol.2005.01.035. Virology. 2005. PMID: 15749129 Free PMC article.

6

Monoclonal antibodies to SARS-associated coronavirus (SARS-CoV): identification of neutralizing and antibodies reactive to S, N, M and E viral proteins.

Tripp RA, Haynes LM, Moore D, Anderson B, Tamin A, Harcourt BH, Jones LP, Yilla M, Babcock GJ, Greenough T, Ambrosino DM, Alvarez R, Callaway J, Cavitt S, Kamrud K, Alterson H, Smith J, Harcourt JL, Miao C, Razdan R, Comer JA, Rollin PE, Ksiazek TG, Sanchez A, Rota PA, Bellini WJ, Anderson LJ. Tripp RA, et al. J Virol Methods. 2005 Sep;128(1-2):21-8. doi: 10.1016/j.jviromet.2005.03.021. J Virol Methods. 2005. PMID: 15885812 Free PMC article.

7

Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association.

Sui J, Li W, Murakami A, Tamin A, Matthews LJ, Wong SK, Moore MJ, Tallarico AS, Olurinde M, Choe H, Anderson LJ, Bellini WJ, Farzan M, Marasco WA. Sui J, et al. Proc Natl Acad Sci U S A. 2004 Feb 24;101(8):2536-41. doi: 10.1073/pnas.0307140101. Proc Natl Acad Sci U S A. 2004. PMID: 14983044 Free PMC article.

8

Development and characterisation of neutralising monoclonal antibody to the SARS-coronavirus.

Berry JD, Jones S, Drebot MA, Andonov A, Sabara M, Yuan XY, Weingartl H, Fernando L, Marszal P, Gren J, Nicolas B, Andonova M, Ranada F, Gubbins MJ, Ball TB, Kitching P, Li Y, Kabani A, Plummer F. Berry JD, et al. J Virol Methods. 2004 Sep 1;120(1):87-96. doi: 10.1016/j.jviromet.2004.04.009. J Virol Methods. 2004. PMID: 15234813 Free PMC article.

9

Development and characterization of a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody that provides effective immunoprophylaxis in mice.

Greenough TC, Babcock GJ, Roberts A, Hernandez HJ, Thomas WD Jr, Coccia JA, Graziano RF, Srinivasan M, Lowy I, Finberg RW, Subbarao K, Vogel L, Somasundaran M, Luzuriaga K, Sullivan JL, Ambrosino DM. Greenough TC, et al. J Infect Dis. 2005 Feb 15;191(4):507-14. doi: 10.1086/427242. Epub 2005 Jan 14. J Infect Dis. 2005. PMID: 15655773 Free PMC article.

10

Molecular characterization of five neutralizing anti-HIV type 1 antibodies: identification of nonconventional D segments in the human monoclonal antibodies 2G12 and 2F5.

Kunert R, Rüker F, Katinger H. Kunert R, et al. AIDS Res Hum Retroviruses. 1998 Sep 1;14(13):1115-28. doi: 10.1089/aid.1998.14.1115. AIDS Res Hum Retroviruses. 1998. PMID: 9737583

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

95 results

Results by year